Filing Flows › aTYR Pharma (ATYR) › Stock forecast & fair value
aTYR Pharma (ATYR) stock forecast and price target
aTYR Pharma (ATYR) trades at $6.35. 7 analysts' median price target is $140.00 (22×), from $40.00 to $280.00.
aTYR Pharma's latest quarter
aTYR Pharma, Q3 2025: revenue $190K, net loss $25.7M, operating cash flow −$20.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ATYR stock?
The median of 7 analysts' 12-month targets is $140.00, 22× from $6.35; the range is $40.00 to $280.00. The average rating is buy.
Does aTYR Pharma usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is ATYR stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.